SpringWorks Therapeutics Inc. [NASDAQ:SWTX] is seeing significant action in the Healthcare space. SWTX stock booking -1.60 earnings per share.
The tape is active for SpringWorks Therapeutics Inc. [SWTX] and the current price target sits at $54.40.
To add more color to this price target, SWTX’s high over the last year is $58.00 and the low is $50.00. Over the last two 52 weeks, the company is trading 169.48%, while the S&P 500 is trading 0.55%.
Wait and see
Holding a Market Cap of $2.25 billion, SpringWorks Therapeutics Inc. has seen a trading range over the last year of $17.02-$53.63.
For the last five days, SWTX is up from its last closing price. The average shares trading hands each day is 220.55K, with average 10-day volume coming in at 0.24 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for SWTX. When we apply the Elder Force Index to SpringWorks Therapeutics Inc., we are seeing an Elder Force Indicator number of 995039.82.
The company’s enterprise value has gone from $1.50B to $833.38M quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In addition, the company has operating cash flow of -$59.73 million.
Looking at popular technical indicators, the company’s 5-day moving average is 51.03 compared to the 50-day moving average of 45.46. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. SWTX currently holds a 9-day RSI of 71.47%, while 100-day RSI stands at 55.77%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. SWTX’s 9-day MACD is 3.15 and the company’s 100-day MACD stands at 9.60.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 15.58% by insiders and 76.44% by institutions. Regarding institutional holdings, Orbimed Advisors LLC. owns 17.22%, while the second top holder, Bain Capital Life Sciences Investors, LLC, currently owns 16.93%.
Overall, the recommended rating for SWTX is Moderate Buy. Currently, the company has 6 analysts watching the stock, and the average quarterly earnings estimate is -0.48.
To review, the current 1-year target estimate is sitting at 54.40, while the current price 53.03. Based on this, we expect the stock to rise considering the aforementioned fundamentals.